Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02748109 · ClinicalTrials.gov registry record · NA
Assessment and Rehabilitation of Central Sensory Impairments for Balance in mTBI
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 132
- Enrollment target
NCT02748109: Completed NA study, sponsored by Oregon Health and Science University.
NCT02748109 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 132 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02748109, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
Study Summary
Our central hypothesis is that chronic balance deficits after mild traumatic brain injury (mTBI) result from impairments in central sensorimotor integration (CSMI) that may be helped by rehabilitation. There are two objectives of this proposal; the first objective is to characterize balance deficits in people with mTBI. The second objective is to use a novel auditory bio-feedback (ABF) device to improve measures central sensorimotor integration and balance control.
Primary Outcome
An APDM movement monitor will be worn around the waist to gather information on local activity during the day.
Interventions
- BEHAVIORAL Vestibular Rehabilitation
- BEHAVIORAL Vestibular Rehabilitation + audio biofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2016-05-11 |
| Est. Completion | 2019-06-24 |
| Phase | NA |
What the finished NCT02748109 record still lists
NCT02748109 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Vestibular Rehabilitation is the first listed.
NCT02748109 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02748109 about?
NCT02748109 is a clinical study titled "Assessment and Rehabilitation of Central Sensory Impairments for Balance in mTBI". Our central hypothesis is that chronic balance deficits after mild traumatic brain injury (mTBI) result from impairments in central sensorimotor integration (CSMI) that may be helped by rehabilitation. There are two objectives of this proposal; the first objective is to characterize balance deficits...
What is the current status of trial NCT02748109?
This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2016-05-11. Estimated completion is 2019-06-24.
What interventions are being tested in trial NCT02748109?
The interventions under investigation include: Vestibular Rehabilitation (BEHAVIORAL), Vestibular Rehabilitation + audio biofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT02748109?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02748109's enrollment target sits among peer trials
132 729th of 2000 higher than 1,269 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI